Aereo Hits Boston O...
Health Care: Drugs
Aegerion Pharmaceuticals Inc. (AEGR: NASDAQ)
$60.02 -0.09 | -0.15%
05/21/13 - 04:00 PM ET
Growth Rates
| GROWTH RATES |
|---|
| REVENUE (Trailing 12 Quarters) |
| EARNINGS PER SHARE (Trailing 12 Quarters) |
| DIVIDENDS (Trailing 12 Quarters) |
Portfolios with AEGR
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- ContributorStocks With Big Insider Buy...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Rising On Unusual Vo...
- ContributorDrugs Facing FDA Approval i...
- ContributorStocks Rising On Unusal Vol...
- ContributorStocks With Big Insider Buy...
Latest AEGR Headlines from TheStreet
- Aegerion Pharmaceuticals To Announce First Quarter 2013 Financial Results On Tuesday, April 30 04.16.13 | 08:04 am
- Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program 04.03.13 | 04:04 pm
- Most Profitable Second Quarter Biotech Stocks 04.02.13 | 06:04 am
- 10 Stocks Insiders And Hedge Funds Think Will Go Higher 03.11.13 | 01:03 pm
- Aegerion Pharmaceuticals Announces Fourth-Quarter And Year-End 2012 Financial Results 03.06.13 | 07:03 am
- Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program 03.05.13 | 04:03 pm
- 5 Stocks Set to Soar on Bullish Earnings 03.04.13 | 01:03 pm
- Aegerion Pharmaceuticals Observes Rare Disease Day 02.28.13 | 08:02 am
- Aegerion Pharmaceuticals Announces Presentation At The Cowen And Company 33rd Annual Health Care Conference 02.27.13 | 08:02 am
- Aegerion Pharmaceuticals To Announce Fourth Quarter 2012 Financial Results On Wednesday, March 6 02.20.13 | 08:02 am
Press Releases for AEGR
- Insmed Appoints Will Lewis As President And Chief Executive Officer - PR Newswire 09.11.12 | 08:09 am
- Aegerion Pharmaceuticals Chief Executive Officer Marc D. Beer (Video: Business Wire) - Business Wire 09.29.11 | 08:09 am
Partner Headlines for AEGR
- Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Propel Insmed - Seeking Alpha 05.14.13 | 10:05 am
- Insider Buying Trends: Are These Cash Rich Companies Ready To Rally? - Seeking Alpha 03.15.13 | 09:03 am
- UPDATE: Canaccord Genuity Raises PT to $44 on Aegerion Pharmaceuticals on Encouraging Sales Data - Benzinga 03.07.13 | 01:03 pm
- UPDATE: Deutsche Bank Raises PT on Aegerion Pharmaceuticals on Strong Juxtapid Uptake - Benzinga 03.06.13 | 01:03 pm
- Pre-Market Earnings Report for March 6, 2013 : SPLS, BF/B, AEO, TFM, BIG, AEGR, HOV, WD, TRK, QRE, WILN, MFB - NASDAQ 03.05.13 | 09:03 pm
- Calendar Spreads On Intuitive Surgical, Riverbed Technology And Sandisk - Seeking Alpha 10.19.12 | 09:10 am
- Benzinga Mid-Day Market Update - Benzinga 10.17.12 | 12:10 pm
- 5 Pharmaceutical Companies With EMA Catalysts During The Next 3 - 12 Months - Part II - Seeking Alpha 09.02.12 | 08:09 am
- Aegerion Pharmaceuticals Announces Date of FDA Advisory Committee Review of Lomitapide NDA - Benzinga 08.14.12 | 09:08 am
- 16 Healthcare Stocks Deeply Discounted From Target Price - Seeking Alpha 01.12.12 | 09:01 am
